Metastatic cancer cells, besides releasing numerous paracrine factors, e.g., parathyroid hormone-related peptide (PTHrP) and interleukin 6 (IL-6), also affect the immune system, vascular endothelium, nerve cells, and platelets [4,5]. This evidence concerns the gene IL6 and cancer.